| For: | Du QC, Ge YY, Xiao WL, Wang WF. Dopamine agonist responsive burning mouth syndrome: Report of eight cases. World J Clin Cases 2021; 9(23): 6916-6921 [PMID: 34447842 DOI: 10.12998/wjcc.v9.i23.6916] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i23/6916.htm |
| Number | Citing Articles |
| 1 |
Layla Mazdeyasnan, Zian Shabbir, Francisco Ibarra. What’s Hot, What’s Not: Review of Pharmacological Options for Managing Burning Mouth Syndrome. Annals of Pharmacotherapy 2026; 60(6) doi: 10.1177/10600280251386558
|
| 2 |
Yoshiaki Saito, Noriko Sumitomo, Takashi Saito, Ayano Kimura, Michio Fukumizu, Shinya Asato, Kazuo Kodama, Kentaro Matsui. Periodic limb movements during sleep in Lesch-Nyhan syndrome. Brain and Development 2026; 48(4) doi: 10.1016/j.braindev.2026.104560
|
| 3 |
Charlotte Moreau, Chakib El Habnouni, Jean-Claude Lecron, Franck Morel, Adriana Delwail, Christelle Le Gall-Ianotto, Raphaele Le Garrec, Laurent Misery, Eric Piver, Loïc Vaillant, Antoine Lefevre, Patrick Emond, Hélène Blasco, Mahtab Samimi. Salivary metabolome indicates a shift in tyrosine metabolism in patients with burning mouth syndrome: a prospective case–control study. Pain 2023; 164(3) doi: 10.1097/j.pain.0000000000002733
|
| 4 |
Rosany O. Lisboa, Raymond F. Sekula, Mariana Bezamat, Kathleen Deeley, Luiz Carlos Santana-da-Silva, Alexandre R. Vieira, JJ Cray. Pain perception genes, asthma, and oral health: A reverse genetics study. PLOS ONE 2022; 17(11) doi: 10.1371/journal.pone.0277036
|
| 5 |
Takahiko Nagamine. Potential Target Receptors for the Pharmacotherapy of Burning Mouth Syndrome. Pharmaceuticals 2025; 18(6) doi: 10.3390/ph18060894
|